Stellungnahme im Rahmen der EU-Konsultation zum Rechtsaktentwurf „Drug resistance – list of antimicrobial medicines reserved for treating humans“

Report an error

Summary

AI-generated

This summary is written by a language model reading the source document. It is not the publisher's words and is not a substitute for the original.

Learn more about AI enrichment

Germanwatch criticizes the EU's draft legal act on antimicrobial resistance for not reserving any additional antibiotics for human use, specifically calling for the protection of Highest Priority Critically Important Antimicrobials (HP CIA) from use in livestock.

Key insights

AI-generated

These insights are written by a language model reading the source document. They are not the publisher's words and are not a substitute for the original.

Learn more about AI enrichment
  • The current draft of the legal act is viewed as inadequate because it does not reserve any additional antibiotics for human use that are currently approved for veterinary medicine, thereby failing to provide added value over the existing situation.
  • Germanwatch specifically highlights the failure to protect antibiotics classified by the WHO as Highest Priority Critically Important Antimicrobials (HP CIA), which the WHO recommends should not be used in food-producing animals.
  • The document argues that the European Medicines Agency (EMA) recommendation should be revised to reflect current knowledge, noting that Colistin is already largely dispensable in some European countries due to improved hygiene and vaccination measures.
  • The author contends that the EU Commission has insufficiently weighted public health interests and the views of human medical institutions, such as the Standing Committee of European Doctors (CPME), in the draft.

Cite the original document

APA
Germanwatch (2022). Stellungnahme im Rahmen der EU-Konsultation zum Rechtsaktentwurf „Drug resistance – list of antimicrobial medicines reserved for treating humans“. https://www.germanwatch.org/sites/default/files/stellungnahme_germanwatch_antibiotika-rechtsakt_16.05.2022_1.pdf
Chicago
Germanwatch. Stellungnahme im Rahmen der EU-Konsultation zum Rechtsaktentwurf „Drug resistance – list of antimicrobial medicines reserved for treating humans“. 2022. https://www.germanwatch.org/sites/default/files/stellungnahme_germanwatch_antibiotika-rechtsakt_16.05.2022_1.pdf.
Wikipedia
{{cite press release |author=Germanwatch |title=Stellungnahme im Rahmen der EU-Konsultation zum Rechtsaktentwurf „Drug resistance – list of antimicrobial medicines reserved for treating humans“ |date=16 May 2022 |url=https://www.germanwatch.org/sites/default/files/stellungnahme_germanwatch_antibiotika-rechtsakt_16.05.2022_1.pdf |access-date=5 November 2026 |via=Climate Insights Directory (document gerwat-002068)}}
BibTeX
@misc{germanwatch2022stellungnahme, author = {{Germanwatch}}, title = {{Stellungnahme im Rahmen der EU-Konsultation zum Rechtsaktentwurf „Drug resistance – list of antimicrobial medicines reserved for treating humans“}}, publisher = {Germanwatch}, year = {2022}, month = may, url = {https://www.germanwatch.org/sites/default/files/stellungnahme_germanwatch_antibiotika-rechtsakt_16.05.2022_1.pdf}, urldate = {2026-11-05}, note = {Indexed by Climate Insights Directory, document gerwat-002068} }

Full text

Collected · Record updated